2003
DOI: 10.1016/s0360-3016(03)00129-9
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of treatment results in advanced Hodgkin’s disease: the case for adjuvant radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2003
2003
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…In humans, treatment modalities for HD differ from conventional chemotherapeutic protocols for non‐Hodgkin's lymphoma. ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) is considered the gold standard for early and intermediate disease, 16 and radiation therapy in bulky disease or partially responsive disease appears to improve survival 17 . The conjunctival Hodgkin's‐like lymphoma in the cat reported here responded poorly to chemotherapy, but rapidly to local radiation therapy.…”
Section: Discussionmentioning
confidence: 84%
“…In humans, treatment modalities for HD differ from conventional chemotherapeutic protocols for non‐Hodgkin's lymphoma. ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) is considered the gold standard for early and intermediate disease, 16 and radiation therapy in bulky disease or partially responsive disease appears to improve survival 17 . The conjunctival Hodgkin's‐like lymphoma in the cat reported here responded poorly to chemotherapy, but rapidly to local radiation therapy.…”
Section: Discussionmentioning
confidence: 84%
“…Despite these limitations, chemoradiotherapy often provides considerable benefit. However, observed inconsistencies in treatment outcomes may be due to the widely varying chemotherapeutic drug concentrations and radiation-absorbed doses used (7)(8)(9)(10). In addition, there is evidence that optimization of radiation dose and drug concentration, and the time sequence for administering drugs and radiation, play important roles in treatment responses both in vitro and in vivo (4,(11)(12)(13).…”
mentioning
confidence: 99%